| RCEEX | VGWLX | RCEEX / VGWLX | |
| Total Expense Ratio | 1.06 | 0.43 | 247% |
| Annual Report Gross Expense Ratio | 1.06 | 0.43 | 247% |
| Fund Existence | 11 years | 8 years | - |
| Gain YTD | 3.529 | 4.993 | 71% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 3000 | 8% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 121B | 2.76B | 4,381% |
| Annual Yield % from dividends | 2.37 | 2.93 | 81% |
| Returns for 1 year | 15.59 | 14.38 | 108% |
| Returns for 3 years | 33.22 | 23.99 | 138% |
| Returns for 5 years | 40.08 | 23.90 | 168% |
| Returns for 10 years | 68.76 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ETAHX | 50.73 | 0.44 | +0.87% |
| Eventide Healthcare & Life Sciences A | |||
| GLOIX | 17.01 | 0.13 | +0.77% |
| Gabelli International Small Cap I | |||
| ESMAX | 13.33 | 0.01 | +0.08% |
| Invesco Global Small Cap Equity A | |||
| DHTYX | 25.75 | -0.03 | -0.12% |
| Diamond Hill Select Y | |||
| CSXAX | 54.88 | -0.53 | -0.96% |
| Calvert US Large Cap Core Rspnb Idx A | |||